Wilson's Disease Industry Research Report 2023

Wilson's Disease Industry Research Report 2023


Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.

Highlights

The global Wilson's Disease market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The classification of Wilson’s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson’s disease. Penicillamine is the most successful drug used for the treatment of Wilson’s disease. Wilson’s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson’s disease is Drugs Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Wilson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wilson's Disease.
The Wilson's Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Wilson's Disease market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wilson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Bausch Health
Teva
Endo International
Univar Solutions
MSN Laboratories
ANI Pharmaceuticals
APOTEX
Tsumura
Sinepharm
Taj Pharmaceutical
Kadmon Holdings

Product Type Insights

Global markets are presented by Wilson's Disease type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Wilson's Disease are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Wilson's Disease segment by Type
Trientine
Penicillamine
Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Wilson's Disease market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Wilson's Disease market.
Wilson's Disease Segment by Application
Hospital
Drugs Stores
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Wilson's Disease market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wilson's Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Wilson's Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Wilson's Disease industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wilson's Disease.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Wilson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Wilson's Disease by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Trientine
1.2.3 Penicillamine
1.2.4 Others
2.3 Wilson's Disease by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Drugs Stores
2.3.4 Others
2.4 Assumptions and Limitations
3 Wilson's Disease Breakdown Data by Type
3.1 Global Wilson's Disease Historic Market Size by Type (2018-2023)
3.2 Global Wilson's Disease Forecasted Market Size by Type (2023-2028)
4 Wilson's Disease Breakdown Data by Application
4.1 Global Wilson's Disease Historic Market Size by Application (2018-2023)
4.2 Global Wilson's Disease Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Wilson's Disease Market Perspective (2018-2029)
5.2 Global Wilson's Disease Growth Trends by Region
5.2.1 Global Wilson's Disease Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Wilson's Disease Historic Market Size by Region (2018-2023)
5.2.3 Wilson's Disease Forecasted Market Size by Region (2024-2029)
5.3 Wilson's Disease Market Dynamics
5.3.1 Wilson's Disease Industry Trends
5.3.2 Wilson's Disease Market Drivers
5.3.3 Wilson's Disease Market Challenges
5.3.4 Wilson's Disease Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Wilson's Disease Players by Revenue
6.1.1 Global Top Wilson's Disease Players by Revenue (2018-2023)
6.1.2 Global Wilson's Disease Revenue Market Share by Players (2018-2023)
6.2 Global Wilson's Disease Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Wilson's Disease Head office and Area Served
6.4 Global Wilson's Disease Players, Product Type & Application
6.5 Global Wilson's Disease Players, Date of Enter into This Industry
6.6 Global Wilson's Disease Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Wilson's Disease Market Size (2018-2029)
7.2 North America Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Wilson's Disease Market Size by Country (2018-2023)
7.4 North America Wilson's Disease Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Wilson's Disease Market Size (2018-2029)
8.2 Europe Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Wilson's Disease Market Size by Country (2018-2023)
8.4 Europe Wilson's Disease Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Wilson's Disease Market Size (2018-2029)
9.2 Asia-Pacific Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Wilson's Disease Market Size by Country (2018-2023)
9.4 Asia-Pacific Wilson's Disease Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Wilson's Disease Market Size (2018-2029)
10.2 Latin America Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Wilson's Disease Market Size by Country (2018-2023)
10.4 Latin America Wilson's Disease Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Wilson's Disease Market Size (2018-2029)
11.2 Middle East & Africa Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Wilson's Disease Market Size by Country (2018-2023)
11.4 Middle East & Africa Wilson's Disease Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Wilson's Disease Introduction
11.1.4 Bausch Health Revenue in Wilson's Disease Business (2017-2022)
11.1.5 Bausch Health Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Wilson's Disease Introduction
11.2.4 Teva Revenue in Wilson's Disease Business (2017-2022)
11.2.5 Teva Recent Development
11.3 Endo International
11.3.1 Endo International Company Detail
11.3.2 Endo International Business Overview
11.3.3 Endo International Wilson's Disease Introduction
11.3.4 Endo International Revenue in Wilson's Disease Business (2017-2022)
11.3.5 Endo International Recent Development
11.4 Univar Solutions
11.4.1 Univar Solutions Company Detail
11.4.2 Univar Solutions Business Overview
11.4.3 Univar Solutions Wilson's Disease Introduction
11.4.4 Univar Solutions Revenue in Wilson's Disease Business (2017-2022)
11.4.5 Univar Solutions Recent Development
11.5 MSN Laboratories
11.5.1 MSN Laboratories Company Detail
11.5.2 MSN Laboratories Business Overview
11.5.3 MSN Laboratories Wilson's Disease Introduction
11.5.4 MSN Laboratories Revenue in Wilson's Disease Business (2017-2022)
11.5.5 MSN Laboratories Recent Development
11.6 ANI Pharmaceuticals
11.6.1 ANI Pharmaceuticals Company Detail
11.6.2 ANI Pharmaceuticals Business Overview
11.6.3 ANI Pharmaceuticals Wilson's Disease Introduction
11.6.4 ANI Pharmaceuticals Revenue in Wilson's Disease Business (2017-2022)
11.6.5 ANI Pharmaceuticals Recent Development
11.7 APOTEX
11.7.1 APOTEX Company Detail
11.7.2 APOTEX Business Overview
11.7.3 APOTEX Wilson's Disease Introduction
11.7.4 APOTEX Revenue in Wilson's Disease Business (2017-2022)
11.7.5 APOTEX Recent Development
11.8 Tsumura
11.8.1 Tsumura Company Detail
11.8.2 Tsumura Business Overview
11.8.3 Tsumura Wilson's Disease Introduction
11.8.4 Tsumura Revenue in Wilson's Disease Business (2017-2022)
11.8.5 Tsumura Recent Development
11.9 Sinepharm
11.9.1 Sinepharm Company Detail
11.9.2 Sinepharm Business Overview
11.9.3 Sinepharm Wilson's Disease Introduction
11.9.4 Sinepharm Revenue in Wilson's Disease Business (2017-2022)
11.9.5 Sinepharm Recent Development
11.10 Taj Pharmaceutical
11.10.1 Taj Pharmaceutical Company Detail
11.10.2 Taj Pharmaceutical Business Overview
11.10.3 Taj Pharmaceutical Wilson's Disease Introduction
11.10.4 Taj Pharmaceutical Revenue in Wilson's Disease Business (2017-2022)
11.10.5 Taj Pharmaceutical Recent Development
11.11 Kadmon Holdings
11.11.1 Kadmon Holdings Company Detail
11.11.2 Kadmon Holdings Business Overview
11.11.3 Kadmon Holdings Wilson's Disease Introduction
11.11.4 Kadmon Holdings Revenue in Wilson's Disease Business (2017-2022)
11.11.5 Kadmon Holdings Recent Development
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings